Abstract
Over the past several decades, rare and unusual fungi have been reported increasingly as agents of infection in humans and animals. This increased frequency of unusual fungal infections may be related in part to increasing numbers of patients with immunosuppression, as well as increased opportunities for environmental exposure to the organisms. In addition, the advent of better diagnostic modalities has aided in the identification of unusual organisms. This review discusses the epidemiology of emerging and unusual fungi and other pathogens causing fungal-like infection.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
